Related Experiment Videos
A survey of recommendations given to patients going home after bone marrow transplant
1Paediatric Oncology Unit, Addenbrooke's Hospital, Cambridge.
Insights
Pediatric bone marrow transplant discharge guidelines lack standardization across UK centers. This variability impacts prophylactic treatments, vaccinations, and patient recovery recommendations, highlighting a need for unified protocols.
Area of Science:
- Pediatric Hematology/Oncology
- Transplant Medicine
- Infectious Disease Prevention
Background:
- Bone marrow transplantation (BMT) is a critical treatment for pediatric cancers.
- Post-transplant care significantly influences patient outcomes and recovery.
- Current discharge instructions for pediatric BMT patients lack uniformity.
Purpose of the Study:
- To assess the variability in discharge instructions provided by UK pediatric bone marrow transplant centers.
- To identify areas of inconsistency in post-transplant care recommendations.
- To highlight the need for standardized BMT discharge guidelines.
Main Methods:
- A postal questionnaire was distributed to 11 UK Children's Cancer Study Group bone marrow transplant centers.
- Nine centers responded, providing details on their discharge instructions.
- Data analysis focused on variations in prophylactic treatments, vaccinations, and recovery recommendations.
Main Results:
- Significant variation exists in prophylactic septrin timing, penicillin prophylaxis, and acyclovir use for herpes simplex.
- Recommendations for varicella-zoster prophylaxis and acyclovir dosing were highly inconsistent.
- Guidelines for vaccinations, school return, holidays, and dietary restrictions showed considerable divergence among centers.
Conclusions:
- There is a critical need for unified, evidence-based guidelines for pediatric bone marrow transplant discharge.
- Standardization of post-transplant care protocols is essential for optimal patient recovery and safety.
- Current practices demonstrate a lack of consensus, necessitating the development of standardized recommendations.
Abstract:
A postal questionnaire was sent to 11 UK Children's Cancer Study Group bone marrow transplant centres asking them for details of their instructions to patients on discharge after either allogeneic or auto transplant; nine centres responded. There was no recommendation on which they all agreed. Though all centres gave prophylactic septrin, the times of starting and stopping treatment varied considerably. Three centres recommended lifelong penicillin after total body irradiation, one treated for two years and five gave no such prophylaxis. Four of nine centres gave routine acyclovir for herpes simplex prophylaxis. Most centres suggested prophylaxis against varicella after contact exposure for one year. However, three gave zoster immune globulin alone, one gave this together with acyclovir, and five gave acyclovir alone. No two centres recommended the same dose of acyclovir. Vaccinations were allowed from 6-18 months after transplant. One centre required documentation of recovery of immune function first. Four centres recommended a child stay off school for six months; others had 'common sense' approaches. Only one centre did not allow family holidays for the first six months but many imposed restrictions on these holidays. Dietary restrictions varied greatly between centres. It is concluded that there is a need for unified and scientifically justified guidelines after transplant for paediatric bone marrow transplant patients.